Stockscreener 앱 받기
9.15
7.77%
0.66
시간 외 거래:
8.98
-0.17
-1.86%
전일 마감가:
$8.49
열려 있는:
$8.43
하루 거래량:
276.92K
Relative Volume:
0.60
시가총액:
$86.17M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-0.9029
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
+14.23%
1개월 성능:
+21.35%
6개월 성능:
-32.62%
1년 성능:
-75.68%
1일 변동 폭
$8.31
$9.23
1주일 범위
$7.82
$9.23
52주 변동 폭
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
KRRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
9.15 | 79.95M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Can Korro Bio Inc. stock outperform in 2025 bull marketWeekly Gains Summary & Long-Term Safe Investment Ideas - ulpravda.ru
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Will Korro Bio Inc. stock keep outperforming rivals2026 world cup usa national team third place match key players low block defense winner prediction expert opinion - ulpravda.ru
Aug Analyst Calls: Will Korro Bio Inc stock see insider buyingWeekly Market Outlook & Entry and Exit Point Strategies - moha.gov.vn
Korro Bio enhances executive compensation and retention incentives - MSN
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Hold” from Analysts - Defense World
Why analysts remain bullish on Korro Bio Inc. stockIPO Watch & Free Low Drawdown Momentum Trade Ideas - Улправда
Can Korro Bio Inc. stock surprise with earnings upsideDividend Hike & Accurate Trade Setup Notifications - Улправда
Will Korro Bio Inc. stock see insider buyingTrade Exit Summary & Real-Time Volume Analysis - bolumsonucanavari.com
Korro Bio (KRRO) price target decreased by 30.77% to 45.90 - MSN
Published on: 2025-12-20 09:40:01 - Улправда
Loss Report: Why Korro Bio Inc. stock remains resilient2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - Улправда
How institutional buying supports Korro Bio Inc. stock2025 Trading Volume Trends & Trade Opportunity Analysis Reports - Улправда
Why Korro Bio Inc. stock remains resilientJuly 2025 WrapUp & Daily Profit Focused Screening - Улправда
How Korro Bio Inc. stock performs after earningsMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
How Korro Bio Inc. stock reacts to oil prices2025 Trading Volume Trends & Stock Portfolio Risk Management - Улправда
Aug Decliners: Will Korro Bio Inc. stock benefit from sector rotation2025 Stock Rankings & Momentum Based Trading Signals - DonanımHaber
BostInnoMass. showing at CES | Korro's $116M Series B - The Business Journals
Korro Bio amends employment agreement with Jeffrey Cerio, increases compensation - Investing.com Canada
Korro Bio Enhances Executive Compensation and Retention Incentives - TipRanks
Korro Bio (KRRO) boosts Jeffrey Cerio salary, severance and RSU grant - Stock Titan
Can Korro Bio Inc. stock resist market sell offsJuly 2025 Retail & AI Enhanced Execution Alerts - Улправда
Will Korro Bio Inc. stock continue dividend increasesMarket Risk Analysis & Fast Moving Stock Trade Plans - Улправда
Why Korro Bio Inc. stock could be next big winner2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Korro Bio (NASDAQ:KRRO) Lowered to Sell Rating by Wall Street Zen - Defense World
Korro Bio downgraded to Hold from Buy at Clear Street - MSN
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - setenews.com
Is Korro Bio Inc a good long term investmentCapital Gains Strategies & Small Entry Cost Stocks - earlytimes.in
Will Magenta Lifecare Limited Stock Continue to Outperform in YEARInsider Trading Activity & Market Volatility Strategies - earlytimes.in
Three new option listings and fifteen option delistings on October 21st - MSN
Korro Bio, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World
Its Stock Has Paid Off Big Time For Korro Bio Inc - Setenews
Korro Bio’s RNA Editing Ambitions Take A Hit After Trial Blowup - Finimize
Would You Still Hold Korro Bio Stock If It Fell Another 30%? - Trefis
Korro Bio downgraded to Perform from Outperform at Oppenheimer - MSN
What high frequency data says about Korro Bio Inc.Portfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Will Korro Bio Inc. stock benefit from automationBear Alert & Technical Analysis for Trade Confirmation - newser.com
What indicators show strength in Korro Bio Inc.Portfolio Value Report & Consistent Income Trade Recommendations - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthPortfolio Performance Summary & Growth Focused Investment Plans - newser.com
What makes Korro Bio Inc. stock attractive to growth fundsJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
What is the fair value of Korro Bio Inc. stock nowJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Korro Bio, Inc.Common Stock (NQ: KRRO - FinancialContent
FY2025 EPS Estimates for Korro Bio Raised by HC Wainwright - Defense World
Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
4.56%
자본화:
|
볼륨(24시간):